These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
345 related items for PubMed ID: 9600224
1. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease. Sheng JG, Mrak RE, Griffin WS. J Neuropathol Exp Neurol; 1998 Apr; 57(4):323-8. PubMed ID: 9600224 [Abstract] [Full Text] [Related]
2. Casein kinase II alteration precedes tau accumulation in tangle formation. Masliah E, Iimoto DS, Mallory M, Albright T, Hansen L, Saitoh T. Am J Pathol; 1992 Feb; 140(2):263-8. PubMed ID: 1739121 [Abstract] [Full Text] [Related]
3. Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages. Sheng JG, Mrak RE, Griffin WS. J Neuropathol Exp Neurol; 1997 Mar; 56(3):285-90. PubMed ID: 9056542 [Abstract] [Full Text] [Related]
4. Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain. Moloney CM, Labuzan SA, Crook JE, Siddiqui H, Castanedes-Casey M, Lachner C, Petersen RC, Duara R, Graff-Radford NR, Dickson DW, Mielke MM, Murray ME. Alzheimers Dement; 2023 Mar; 19(3):1029-1040. PubMed ID: 35920592 [Abstract] [Full Text] [Related]
6. Regional quantitative study of formation process of neurofibrillary tangles in the hippocampus of non-demented elderly brains: comparison with late-onset Alzheimer's disease brains. Takayama N, Iseki E, Yamamoto T, Kosaka K. Neuropathology; 2002 Sep; 22(3):147-53. PubMed ID: 12416553 [Abstract] [Full Text] [Related]
7. The role of neurofibrillary tangles in Alzheimer disease. Brion JP. Acta Neurol Belg; 1998 Jun; 98(2):165-74. PubMed ID: 9686275 [Abstract] [Full Text] [Related]
8. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Augustinack JC, Schneider A, Mandelkow EM, Hyman BT. Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744 [Abstract] [Full Text] [Related]
9. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. Ferrer I, Blanco R, Carmona M, Puig B. J Neural Transm (Vienna); 2001 Jan; 108(12):1397-415. PubMed ID: 11810404 [Abstract] [Full Text] [Related]
11. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease. García-Sierra F, Wischik CM, Harrington CR, Luna-Muñoz J, Mena R. J Chem Neuroanat; 2001 Jul; 22(1-2):65-77. PubMed ID: 11470555 [Abstract] [Full Text] [Related]
12. Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease. Kobayashi K, Nakano H, Hayashi M, Shimazaki M, Fukutani Y, Sasaki K, Sugimori K, Koshino Y. J Neurol Sci; 2003 Apr 15; 208(1-2):17-24. PubMed ID: 12639720 [Abstract] [Full Text] [Related]
13. Comparative distribution of tau phosphorylated at Ser262 in pre-tangles and tangles. Lauckner J, Frey P, Geula C. Neurobiol Aging; 2003 Oct 15; 24(6):767-76. PubMed ID: 12927759 [Abstract] [Full Text] [Related]
14. Are tangles as toxic as they look? Spires-Jones TL, Kopeikina KJ, Koffie RM, de Calignon A, Hyman BT. J Mol Neurosci; 2011 Nov 15; 45(3):438-44. PubMed ID: 21638071 [Abstract] [Full Text] [Related]
15. The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer's disease. Hondius DC, Koopmans F, Leistner C, Pita-Illobre D, Peferoen-Baert RM, Marbus F, Paliukhovich I, Li KW, Rozemuller AJM, Hoozemans JJM, Smit AB. Acta Neuropathol; 2021 Mar 15; 141(3):341-358. PubMed ID: 33492460 [Abstract] [Full Text] [Related]
16. The relationship between amyloid and tau. Hardy J. J Mol Neurosci; 2003 Apr 15; 20(2):203-6. PubMed ID: 12794314 [Abstract] [Full Text] [Related]
17. Phospho-Tau Changes in the Human CA1 During Alzheimer's Disease Progression. Regalado-Reyes M, Furcila D, Hernández F, Ávila J, DeFelipe J, León-Espinosa G. J Alzheimers Dis; 2019 Apr 15; 69(1):277-288. PubMed ID: 30958368 [Abstract] [Full Text] [Related]
18. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I, Barrachina M, Puig B. Acta Neuropathol; 2002 Dec 15; 104(6):583-91. PubMed ID: 12410379 [Abstract] [Full Text] [Related]
19. Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer's disease. Pooler AM, Polydoro M, Maury EA, Nicholls SB, Reddy SM, Wegmann S, William C, Saqran L, Cagsal-Getkin O, Pitstick R, Beier DR, Carlson GA, Spires-Jones TL, Hyman BT. Acta Neuropathol Commun; 2015 Mar 24; 3():14. PubMed ID: 25853174 [Abstract] [Full Text] [Related]
20. Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain. Su JH, Deng G, Cotman CW. Brain Res; 1997 Nov 07; 774(1-2):193-9. PubMed ID: 9452208 [Abstract] [Full Text] [Related] Page: [Next] [New Search]